搜尋結果
This new weight loss drug ETF bets big on two of the industry's leading players
CNBC· 12 小時前A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss ...
Ozempic doesn't make everyone thin. That opens up an opportunity for some stocks
CNBC· 16 小時前It can mean the difference between qualifying for bariatric surgery or not. Or, in other cases, ...
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 4 日前... $5.3 billion into a new manufacturing site, boosting production for its weight ... ...
Nvidia and more: Citi names global stocks to play the semiconductor boom
CNBC· 5 小時前The global semiconductor industry is set to experience "groundbreaking changes," Citi ...
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 3 日前Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 6 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
The Top 10 S&P 500 Stocks By Weight—A Boon Or Bane?
Forbes· 6 日前The S&P 500 index closed Tuesday’s trade at 5,321.41, setting a new all-time high, above the ...
Perseverance of man with hemophilia inspires others
China Daily· 2 小時前Despite standing 1.7 meters tall, Xiao Tan, from Changsha in Hunan province, tries to maintain a weight
Lilly Invests $5.3 Billion to Boost Weight-Loss Drug Supply
Bloomberg· 4 日前Have a confidential tip for our reporters? Eli Lilly & Co. will spend $5.3 billion to boost ...
Triple ONE Champion Malykhin Explains His Reluctance To Move To UFC
telecomasia.net· 12 小時前ONE champion in three weight categories, Russian fighter Anatoliy Malykhin, told why he does ...